Keming Gao, MD
Psychiatry · Cleveland, OHNPI 1003839713
Payments from drug & device makers
What this record shows
4 manufacturers reported payments, led by Sentynl Therapeutics, Inc. at 55.4% of the total.
Across 17 payments — averaging $37.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sentynl Therapeutics, Inc.$353
- Sunovion Pharmaceuticals Inc.$194
- Medtronic$64
- Johnson & Johnson$27
Across 9 payments — averaging $8418.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim International GmbH$34K
- Janssen Research & Development, LLC$28K
- Livanova USA, Inc.$14K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$234
What the payments were for
- Consulting fees$35355%
- Food & beverage$28545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sentynl Therapeutics, Inc. | 1 | $353 |
| Sunovion Pharmaceuticals Inc. | 14 | $194 |
| Medtronic | 1 | $64 |
| Johnson & Johnson | 1 | $27 |
How this compares
$638 in reported general payments places this provider in the 65th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 14 | $21,419 |
| VivitrolNaltrexone Microspheres | 12 | $19,375 |
| Lurasidone Hcl | 19 | $12,736 |
| Modafinil | 25 | $4,152 |
| Lamotrigine | 120 | $2,262 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 26 | $1,747 |
| Bupropion XlBupropion Hcl | 44 | $1,476 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 17 | $1,327 |
| Quetiapine Fumarate | 57 | $1,162 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $1,085 |
| Hydroxyzine Hcl | 24 | $1,052 |
| Clozapine | 24 | $961 |
| Buspirone Hcl | 35 | $918 |
| Methylphenidate Hcl | 13 | $850 |
| Aripiprazole | 26 | $804 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Cleveland
- Binit ShahCleveland$913K
- Martha SajatovicCleveland$102K
- Ketan DeorasCleveland$80K
- Neal GoldenbergCleveland$47K
- Brian BarnettCleveland$21K
- Luis RamirezCleveland$18K
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.